Skip to content

Herpes drug has direct anti-HIV effect, could offer cheap addition to antiretroviral therapy for developing world

South Africa: Questions about new HIV prevalence survey

Security, food, healthcare and transport barriers to adherence in conflict zone

Cidofovir of no benefit for HIV-related PML

African study looks at safety of antiretroviral therapy during pregnancy

Gay men of all ages remain a priority for HIV prevention in the US

MDR-TB may be more infectious, study of HIV patients finds

HIV treatment must lead transformation of primary health care in developing world

Patients staying on first-line HIV treatment combinations for longer

HIV treatment at same time as TB treatment halves death rate in South African study

Survey shows less than 25% getting ARVS in many countries, despite growth in international funding

Switching to AZT from d4T poses challenges in resource-limited settings

PrEP could be cost-effective and avert infections in high-risk MSM: model

Discrimination and distrust not sufficient to explain racial differences in adherence: US study

New UK guidelines recommend normalisation of HIV testing in a wide range of healthcare settings

New maturation inhibitor ready for trials in HIV-positive patients

More evidence that antiretrovirals reduce the risk of non-HIV illnesses at lower CD4 cell counts

Imported malaria often severe among people with HIV